AstraZeneca PLC
LSE:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
LSE:AZN
Watchlist
Price: 10 420 GBX 0.27% Market Closed
Market Cap: 161.6B GBX
Have any thoughts about
AstraZeneca PLC?
Write Note

Intrinsic Value

The intrinsic value of one AZN stock under the Base Case scenario is 14 568.64 GBX. Compared to the current market price of 10 420 GBX, AstraZeneca PLC is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AZN Intrinsic Value
14 568.64 GBX
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
AstraZeneca PLC

Valuation History Unavailable

Historical valuation for AZN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
Compare AZN to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AZN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about AstraZeneca PLC

Provide an overview of the primary business activities
of AstraZeneca PLC.

What unique competitive advantages
does AstraZeneca PLC hold over its rivals?

What risks and challenges
does AstraZeneca PLC face in the near future?

Has there been any significant insider trading activity
in AstraZeneca PLC recently?

Summarize the latest earnings call
of AstraZeneca PLC.

What significant events have occurred
in AstraZeneca PLC over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AstraZeneca PLC.

Provide P/S
for AstraZeneca PLC.

Provide P/E
for AstraZeneca PLC.

Provide P/OCF
for AstraZeneca PLC.

Provide P/FCFE
for AstraZeneca PLC.

Provide P/B
for AstraZeneca PLC.

Provide EV/S
for AstraZeneca PLC.

Provide EV/GP
for AstraZeneca PLC.

Provide EV/EBITDA
for AstraZeneca PLC.

Provide EV/EBIT
for AstraZeneca PLC.

Provide EV/OCF
for AstraZeneca PLC.

Provide EV/FCFF
for AstraZeneca PLC.

Provide EV/IC
for AstraZeneca PLC.

Show me price targets
for AstraZeneca PLC made by professional analysts.

What are the Revenue projections
for AstraZeneca PLC?

How accurate were the past Revenue estimates
for AstraZeneca PLC?

What are the Net Income projections
for AstraZeneca PLC?

How accurate were the past Net Income estimates
for AstraZeneca PLC?

What are the EPS projections
for AstraZeneca PLC?

How accurate were the past EPS estimates
for AstraZeneca PLC?

What are the EBIT projections
for AstraZeneca PLC?

How accurate were the past EBIT estimates
for AstraZeneca PLC?

Compare the revenue forecasts
for AstraZeneca PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AstraZeneca PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AstraZeneca PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of AstraZeneca PLC compared to its peers.

Compare the P/E ratios
of AstraZeneca PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing AstraZeneca PLC with its peers.

Analyze the financial leverage
of AstraZeneca PLC compared to its main competitors.

Show all profitability ratios
for AstraZeneca PLC.

Provide ROE
for AstraZeneca PLC.

Provide ROA
for AstraZeneca PLC.

Provide ROIC
for AstraZeneca PLC.

Provide ROCE
for AstraZeneca PLC.

Provide Gross Margin
for AstraZeneca PLC.

Provide Operating Margin
for AstraZeneca PLC.

Provide Net Margin
for AstraZeneca PLC.

Provide FCF Margin
for AstraZeneca PLC.

Show all solvency ratios
for AstraZeneca PLC.

Provide D/E Ratio
for AstraZeneca PLC.

Provide D/A Ratio
for AstraZeneca PLC.

Provide Interest Coverage Ratio
for AstraZeneca PLC.

Provide Altman Z-Score Ratio
for AstraZeneca PLC.

Provide Quick Ratio
for AstraZeneca PLC.

Provide Current Ratio
for AstraZeneca PLC.

Provide Cash Ratio
for AstraZeneca PLC.

What is the historical Revenue growth
over the last 5 years for AstraZeneca PLC?

What is the historical Net Income growth
over the last 5 years for AstraZeneca PLC?

What is the current Free Cash Flow
of AstraZeneca PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for AstraZeneca PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AstraZeneca PLC

Current Assets 26.1B
Cash & Short-Term Investments 5.4B
Receivables 14.8B
Other Current Assets 5.9B
Non-Current Assets 80.1B
Long-Term Investments 1.9B
PP&E 12.3B
Intangibles 58.7B
Other Non-Current Assets 7.2B
Current Liabilities 29.1B
Accounts Payable 22.5B
Short-Term Debt 1.4B
Other Current Liabilities 5.2B
Non-Current Liabilities 36.1B
Long-Term Debt 27.9B
Other Non-Current Liabilities 8.2B
Efficiency

Free Cash Flow Analysis
AstraZeneca PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
AstraZeneca PLC

Revenue
55B USD
Cost of Revenue
-9.7B USD
Gross Profit
45.3B USD
Operating Expenses
-32.1B USD
Operating Income
13.2B USD
Other Expenses
-5.5B USD
Net Income
7.8B USD
Fundamental Scores

AZN Profitability Score
Profitability Due Diligence

AstraZeneca PLC's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

63/100
Profitability
Score

AstraZeneca PLC's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

AZN Solvency Score
Solvency Due Diligence

AstraZeneca PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
47/100
Solvency
Score

AstraZeneca PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AZN Price Targets Summary
AstraZeneca PLC

Wall Street analysts forecast AZN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AZN is 13 530.29 GBX with a low forecast of 6 864.74 GBX and a high forecast of 18 270 GBX.

Lowest
Price Target
6 864.74 GBX
34% Downside
Average
Price Target
13 530.29 GBX
30% Upside
Highest
Price Target
18 270 GBX
75% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AZN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AZN Insider Trading
Buy and sell transactions by insiders

AZN News

Other Videos
What is the Intrinsic Value of one AZN stock?

The intrinsic value of one AZN stock under the Base Case scenario is 14 568.64 GBX.

Is AZN stock undervalued or overvalued?

Compared to the current market price of 10 420 GBX, AstraZeneca PLC is Undervalued by 28%.

Back to Top